Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030Ramat Gan, Israel, Feb. 18, 2025 (GLOBE ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

The risk of developing liver cancer is increased in people who have cirrhosis, a disease in which healthy liver tissue is ...

Can-Fite BioPharma (CANF) announced a significant clinical development: the disappearance of episodes of decompensated liver cirrhosis ...

There has been a tremendous rise in the number of deaths in Goa due to alcohol-related liver cirrhosis in youngsters, ...

Innovative therapies and surgical techniques have the potential to transform liver cancer care. People with cirrhosis—a ...

Veteran Actor Uttam Mohanty in Critical Condition, Flown to Delhi for Liver Cirrhosis Treatment. Read on to know more.

Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...

Goa is witnessing a worrying trend of rising alcohol-related health issues, with over 300 deaths annually due to liver ...

The U.S. market for liver cirrhosis treatment is projected to grow to approximately $15 billion by 2030.

The U.S. market for liver cirrhosis treatment is projected to grow to approximately $15 billion by 2030. Namodenoson is a small orally bioavailable drug that binds with high affinity and ...